Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32...

Area of Science:

• Hepatology
• Molecular Biology
• Cancer Research

Background:

• Connexin 32 (Cx32) is a key gap junction protein in hepatocytes.
• Understanding Cx32's role in liver regeneration and cancer is crucial for therapeutic development.

Purpose of the Study:

• To investigate Cx32 expression changes after partial hepatectomy (PH) in rats.
• To analyze Cx32 levels during hepatocarcinogenesis, from preneoplastic lesions to hepatocellular carcinoma (HCC).
• To correlate Cx32 expression with cell proliferation and altered enzyme expression.

Main Methods:

• Quantitative immunohistochemistry was used to measure Cx32 protein spots on hepatocyte membranes.
• Livers were analyzed sequentially after PH and during chemically induced carcinogenesis (N-ethyl-N-hydroxyethylnitrosamine).
• Cell proliferation was assessed using 5-bromo-2'-deoxyuridine (BrdU) labeling indices.

Main Results:

• Cx32 expression rapidly decreased after PH, reaching lowest levels during the S phase of cell proliferation.
• A progressive decline in Cx32 was observed from enzyme-altered foci (EAF) to hyperplastic nodules (HN) and HCC.
• Pulmonary metastatic and transplanted HCC showed zero Cx32 expression.
• Inverse correlations were found between Cx32 levels, BrdU index, and altered enzyme expression in HN.

Conclusions:

• Cx32 downregulation is closely linked to hepatocyte proliferation and the progression of liver cancer.
• Decreased Cx32 expression may signify increased cellular independence and growth advantage, contributing to hepatocarcinogenesis.
• Cx32 levels can serve as a biomarker for assessing the proximity of preneoplastic lesions to HCC.